NCT05090254

Brief Summary

Perioperative cardiac output-guided goal-directed therapy (GDT) triggers fluid, vasopressor, and inotrope administration assuming that optimizing cardiac output (i.e., global blood flow) ensures adequate oxygen delivery and microcirculatory perfusion - that are usually not directly monitored during goal-directed therapy. There is increasing evidence that perioperative cardiac output-guided goal-directed therapy may reduce postoperative complications compared to routine hemodynamic management in high-risk patients having major surgery. The effect of cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as microcirculatory perfusion, however, is unknown. The investigators aim to investigate the effect of using different cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as sublingual microcirculatory perfusion compared to routine perioperative hemodynamic management in patients having major abdominal surgery with general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

August 29, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 22, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2022

Completed
Last Updated

June 30, 2022

Status Verified

June 1, 2022

Enrollment Period

10 months

First QC Date

August 29, 2021

Last Update Submit

June 29, 2022

Conditions

Keywords

non-cardiac surgeryoxygen consumptionoxygen deliverymicrocirculatory perfusiongoal-directed hemodynamic therapy

Outcome Measures

Primary Outcomes (2)

  • Perioperative changes in oxygen delivery

    assessed via blood gas analysis

    after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery

  • Perioperative changes in oxygen consumption

    assessed via indirect calorimetry

    baseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery

Secondary Outcomes (2)

  • Perioperative changes of microcirculation

    baseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery

  • Perioperative changes in cardiac output

    baseline awake, after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery

Other Outcomes (3)

  • Incidence of postoperative myocardial injury

    baseline awake, within 6 hours after surgery, and on day 1, 2, and 3 after surgery

  • Incidence of acute kidney injury

    baseline awake, within 6 hours after surgery, and on day 1, 2, and 3 after surgery

  • Perioperative changes in urethral perfusion index

    after induction of general anesthesia, during the last 30 minutes of surgery, within 6 hours after surgery, day 1, 2, 3 after surgery

Study Arms (3)

Cardiac output maximization group

ACTIVE COMPARATOR

Patients will be treated according to a goal-directed therapy protocol aiming at a cardiac output maximization. Detailed protocol adapted from Edwards, M.R., et al., Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. BMJ Open, 2019. 9(1): p. e023455.

Other: Treatment algorithms targeting cardiac output

Cardiac output personalization group

ACTIVE COMPARATOR

Patients will be treated according to a goal-directed therapy protocol aiming at a personalized cardiac output goal determined with preoperative cardiac output assessment. Detailed protocol adapted from Nicklas, J.Y., et al., Personalised haemodynamic management targeting baseline cardiac index in high-risk patients undergoing major abdominal surgery: a randomised single-centre clinical trial. Br J Anaesth, 2020. 125(2): p. 122-132.

Other: Treatment algorithms targeting cardiac output

Routine management group

NO INTERVENTION

Patients will be treated according to routine hemodynamic management.

Interventions

Treatment algorithms targeting maximization or personalization of cardiac output

Cardiac output maximization groupCardiac output personalization group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (≥18 years) having elective major abdominal surgery with general anesthesia
  • Expected duration of surgery at least 120 minutes
  • Planned postoperative monitoring in intensive care unit

You may not qualify if:

  • Emergency surgery
  • Age \<18 years
  • Body weight \<50 kg
  • Pregnancy
  • Atrial fibrillation
  • Planned patient positioning in other position than supine position
  • Surgery within the last 30 days
  • Inaccessibility of the head during surgery
  • Peripheral artery disease stage ≥IIb
  • Chronic vasculitis
  • Supraglottic airway management
  • Enterostomy repair surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Hamburg-Eppendorf

Hamburg, 20246, Germany

Location

Study Officials

  • Bernd Saugel, Prof., MD

    The University Medical Center Hamburg-Eppendorf

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2021

First Posted

October 22, 2021

Study Start

August 1, 2021

Primary Completion

May 31, 2022

Study Completion

May 31, 2022

Last Updated

June 30, 2022

Record last verified: 2022-06

Locations